Hepatotoxicity of Antituberculosis Therapy (HAT) Study
NCT04159441
·
clinicaltrials.gov ↗
UNKNOWN
Status
5000
Enrollment
OTHER
Sponsor class
Conditions
Chemical and Drug Induced Liver Injury
Interventions
OTHER:
None intervetion
Sponsor
Huashan Hospital